Literature DB >> 4595749

Hexamethylmelamine--a new drug with activity in solid tumors.

R H Blum, R B Livingston, S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4595749     DOI: 10.1016/s0014-2964(73)80019-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  9 in total

1.  The chemotherapy of large-bowel cancer. Present status and future prospects.

Authors:  J Horton; C B Hacker; T J Cunningham; R W Sponzo
Journal:  Am J Dig Dis       Date:  1974-11

Review 2.  Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.

Authors:  F M Torti; W G Harker
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Human central nervous system pharmacology of pentamethylmelamine and its metabolites.

Authors:  D J Stewart; J A Benvenuto; M Leavens; R G Smith; F Cabanillas; R S Benjamin; T L Loo
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

Review 4.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.

Authors:  K J Miller; R M McGovern; M M Ames
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 6.  Clinical pharmacokinetics of altretamine.

Authors:  G Damia; M D'Incalci
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

7.  Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.

Authors:  I R Judson; C J Rutty; G Abel; M A Graham
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

8.  Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.

Authors:  M D'Incalci; E Erba; G Balconi; L Morasca; S Garattini
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

Review 9.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.